Danish Pfizer-director promoted to international top position
By the end of November, Henriette Dræbye Rosenquist steps down as managing director in Pfizer Denmark and chairman in the Danish Association of the Pharmaceutical Industry (Lif). Pfizer already found her successor internally in the organization.
CEO Ian Read's upcoming exit has caused many organizational changes in US drug group Pfizer. The restructuring also affects the company's Danish unit, which this week announced that managing director Henriette Dræbye Rosenquist leaves the Danish office in the end of November.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
